Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics

By De Nayer A   Larmo I   Lindenbauer B   Rittmannsberger H   Platz T   Jones Am   Whiteford Jl   Altman Ca   Windhager E    

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 59-66

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia

By Gibert Juan   Giner José   Bobes Julio   Tafalla Mónica   Herranz Santiago   Ovejero Carmen   Rico-Villademoros Fernando   GROUP for the SOS  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 3, 2007-01 ,pp. : 222-232

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study

By Lee Phil   Eung Kim Chul   Yoon Kim Chang   Lin Wei-Wen   Habil Hussain   Dyachkova Yulia   Mcbride Margaret   Dossenbach Martin  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 215-227

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Sertindole is associated with a low level of extrapyramidal symptoms in schizophrenic patients: Results of a phase III trial

By Hale Anthony   Azorin Jean-Michel   Kasper Siegfried   Maier Wolfgang   Syvalahti Erkka   Burght Michael Van Der   Sloth-Nielsen Mogens   Wehnert Allan  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 1, 2000-03 ,pp. : 47-54

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia

By Buckley P.F.   Goldstein J.M.   Emsley R.A.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite